On December 01st, 2016, Diplomat Pharmacy announced that it will be dispensing DARZALEX (daratumumab) in combination with REVLIMID (lenalidomide) and dexamethasone or with VELCADE (bortezomib) and dexamethasone. DARZALEX was recently approved by the Food and Drug Administration to treat patients with multiple myeloma who have received at least one other treatment.

]]>https://dev.proinvestor.com/forum/topic/398443/on-december-01st-2016-diplomat-pharmacy-announced-that-it-will-be-dispensing-darzalex-daratumumab-in-combination-with-revlimid-lenalidomide-and-dexamethasone-or-with-velcade-bortezomib-andRSS for NodeSun, 07 Jun 2026 06:31:03 GMTSat, 09 Dec 2023 12:10:45 GMT60